Hyogo, Japan

Shohei Aikawa

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shohei Aikawa: Innovator in Pharmaceutical Preparations

Introduction

Shohei Aikawa is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance light stability and dissolution properties. With a total of 2 patents, Aikawa's work is recognized for its innovative approach to drug formulation.

Latest Patents

Aikawa's latest patents include a pharmaceutical preparation that excels in light stability and dissolution property. This invention provides a minimally colored preparation through irradiation with light by coating a compound with a light stabilizing substance and a polymer. The formulation utilizes titanium oxide and talc as light stabilizing substances, along with hypromellose as the polymer. Another significant patent is for a solid dosage form containing a quinazoline derivative. This formulation also incorporates a light-stabilizing substance and a polymer, ensuring minimal increase in related substances and maintaining a colorless appearance under light irradiation.

Career Highlights

Shohei Aikawa is associated with Shionogi Company Limited, where he continues to innovate in pharmaceutical formulations. His work has contributed to advancements in drug stability and efficacy, making a positive impact on the pharmaceutical industry.

Collaborations

Aikawa collaborates with talented coworkers, including Naomi Hayashi and Masato Gomi. Their combined expertise fosters a creative environment that drives innovation in their projects.

Conclusion

Shohei Aikawa's contributions to pharmaceutical preparations highlight his role as a key innovator in the industry. His patents reflect a commitment to improving drug formulations, ensuring they are effective and stable under various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…